National Round The Clock Hot Line
1-888-365-4458(US)  44-808-111-0143(EU)
86-108-294-5717(AS)
go to cart
1 2 3 4 5

Email Subscribe


Your Position:Home > Medical > Global (United States, European Union and China) Tofacitinib Market Research Report 2019-2025

Global (United States, European Union and China) Tofacitinib Market Research Report 2019-2025

Goods_sn:xuxiaojuan-gz3

Publishers:QYResearch

Numbers:Share

Price:

License: single license enterprise license

Global (United States, European Union and China) Tofacitinib Market Research Report 2019-2025

Hard Copy: 3280 USD
PDF Copy (single user): 3280 USD
Multi User License: 4920 USD
Enterprise wide License: 6560 USD
Pages: 95
Tables and Figures: 103
Published Date: May 2019
Publisher: QYR Pharma & Healthcare Research Center
Contact: Tel: 1-6262952442; 86-10-82945717; Email: sales@qyresearch.com

Scope of the Report

In 2019, the market size of Tofacitinib is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Tofacitinib.

This report studies the global market size of Tofacitinib, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Tofacitinib sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
    Pfizer
    Globe Pharmaceuticals
    Delta Pharma Limited
    Beacon Pharmaceuticals
    Drug International
    ...

Market Segment by Product Type
    5mg*60 Tablets
    5mg*10 Tablets
    10mg*10 Tablets
    5mg*30 Tablets
    5mg*14 Tablets
    10mg*14 Tablets

Market Segment by Application
    Rheumatoid Arthritis
    Ulcerative Colitis
    Psoriasis
    Other

Key Regions split in this report: breakdown data for each region.
    United States
    China
    European Union
    Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
    To analyze and research the Tofacitinib status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
    To present the key Tofacitinib manufacturers, presenting the sales, revenue, market share, and recent development for key players.
    To split the breakdown data by regions, type, companies and applications
    To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
    To identify significant trends, drivers, influence factors in global and regions
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Tofacitinib are as follows:
    History Year: 2014-2018
    Base Year: 2018
    Estimated Year: 2019
    Forecast Year 2019 to 2025


Table of Contents

1 Report Overview
    1.1 Study Scope
    1.2 Major Manufacturers Covered in This Report
    1.3 Market Segment by Type
        1.3.1 Global Tofacitinib Market Size Growth Rate by Type (2019-2025)
        1.3.2 5mg*60 Tablets
        1.3.3 5mg*10 Tablets
        1.3.4 10mg*10 Tablets
        1.3.5 5mg*30 Tablets
        1.3.6 5mg*14 Tablets
        1.3.7 10mg*14 Tablets
    1.4 Market Segment by Application
        1.4.1 Global Tofacitinib Market Share by Application (2019-2025)
        1.4.2 Rheumatoid Arthritis
        1.4.3 Ulcerative Colitis
        1.4.4 Psoriasis
        1.4.5 Other
    1.5 Study Objectives
    1.6 Years Considered

2 Global Growth Trends
    2.1 Global Tofacitinib Market Size
        2.1.1 Global Tofacitinib Revenue 2014-2025
        2.1.2 Global Tofacitinib Sales 2014-2025
    2.2 Tofacitinib Growth Rate by Regions
        2.2.1 Global Tofacitinib Sales by Regions 2014-2019
        2.2.2 Global Tofacitinib Revenue by Regions 2014-2019
    2.3 Industry Trends
        2.3.1 Market Top Trends
        2.3.2 Market Drivers

3 Market Share by Manufacturers
    3.1 Tofacitinib Sales by Manufacturers
        3.1.1 Tofacitinib Sales by Manufacturers 2014-2019
        3.1.2 Tofacitinib Sales Market Share by Manufacturers 2014-2019
    3.2 Revenue by Manufacturers
        3.2.1 Tofacitinib Revenue by Manufacturers (2014-2019)
        3.2.2 Tofacitinib Revenue Share by Manufacturers (2014-2019)
        3.2.3 Global Tofacitinib Market Concentration Ratio (CR5 and HHI)
    3.3 Tofacitinib Price by Manufacturers
    3.4 Key Manufacturers Tofacitinib Plants/Factories Distribution and Area Served
    3.5 Date of Key Manufacturers Enter into Tofacitinib Market
    3.6 Key Manufacturers Tofacitinib Product Offered
    3.7 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
    4.1 Sales and Revenue for Each Type
        4.1.1 5mg*60 Tablets Sales and Revenue (2014-2019)
        4.1.2 5mg*10 Tablets Sales and Revenue (2014-2019)
        4.1.3 10mg*10 Tablets Sales and Revenue (2014-2019)
        4.1.4 5mg*30 Tablets Sales and Revenue (2014-2019)
        4.1.5 5mg*14 Tablets Sales and Revenue (2014-2019)
        4.1.6 10mg*14 Tablets Sales and Revenue (2014-2019)
    4.2 Global Tofacitinib Sales Market Share by Type
    4.3 Global Tofacitinib Revenue Market Share by Type
    4.4 Tofacitinib Price by Type

5 Market Size by Application
    5.1 Overview
    5.2 Global Tofacitinib Sales by Application

6 United States
6.1 United States Tofacitinib Breakdown Data by Company
6.2 United States Tofacitinib Breakdown Data by Type
6.3 United States Tofacitinib Breakdown Data by Application

7 European Union
7.1 European Union Tofacitinib Breakdown Data by Company
7.2 European Union Tofacitinib Breakdown Data by Type
7.3 European Union Tofacitinib Breakdown Data by Application

8 China
8.1 China Tofacitinib Breakdown Data by Company
8.2 China Tofacitinib Breakdown Data by Type
8.3 China Tofacitinib Breakdown Data by Application

9 Rest of World
    9.1 Rest of World Tofacitinib Breakdown Data by Company
    9.2 Rest of World Tofacitinib Breakdown Data by Type
    9.3 Rest of World Tofacitinib Breakdown Data by Application
    9.4 Rest of World Tofacitinib Breakdown Data by Countries
        9.4.1 Rest of World Tofacitinib Sales by Countries
        9.4.2 Rest of World Tofacitinib Revenue by Countries
        9.4.3 Japan
        9.4.4 Korea
        9.4.5 India
        9.4.6 Southeast Asia

10 Company Profiles
    10.1 Pfizer
        10.1.1 Pfizer Company Details
        10.1.2 Company Description and Business Overview
        10.1.3 Sales, Revenue and Market Share of Tofacitinib
        10.1.4 Tofacitinib Product Introduction
        10.1.5 Pfizer Recent Development
    10.2 Globe Pharmaceuticals
        10.2.1 Globe Pharmaceuticals Company Details
        10.2.2 Company Description and Business Overview
        10.2.3 Sales, Revenue and Market Share of Tofacitinib
        10.2.4 Tofacitinib Product Introduction
        10.2.5 Globe Pharmaceuticals Recent Development
    10.3 Delta Pharma Limited
        10.3.1 Delta Pharma Limited Company Details
        10.3.2 Company Description and Business Overview
        10.3.3 Sales, Revenue and Market Share of Tofacitinib
        10.3.4 Tofacitinib Product Introduction
        10.3.5 Delta Pharma Limited Recent Development
    10.4 Beacon Pharmaceuticals
        10.4.1 Beacon Pharmaceuticals Company Details
        10.4.2 Company Description and Business Overview
        10.4.3 Sales, Revenue and Market Share of Tofacitinib
        10.4.4 Tofacitinib Product Introduction
        10.4.5 Beacon Pharmaceuticals Recent Development
    10.5 Drug International
        10.5.1 Drug International Company Details
        10.5.2 Company Description and Business Overview
        10.5.3 Sales, Revenue and Market Share of Tofacitinib
        10.5.4 Tofacitinib Product Introduction
        10.5.5 Drug International Recent Development

11 Value Chain and Sales Channels Analysis
    11.1 Value Chain Analysis
    11.2 Sales Channels Analysis
        11.2.1 Tofacitinib Sales Channels
        11.2.2 Tofacitinib Distributors
    11.3 Tofacitinib Customers

12 Market Forecast
    12.1 Global Tofacitinib Sales and Revenue Forecast 2019-2025
    12.2 Global Tofacitinib Sales Forecast by Type
    12.3 Global Tofacitinib Sales Forecast by Application
    12.4 Tofacitinib Forecast by Regions
        12.4.1 Global Tofacitinib Sales Forecast by Regions 2019-2025
        12.4.2 Global Tofacitinib Revenue Forecast by Regions 2019-2025
    12.5 United States Market Forecast
    12.6 European Union Market Forecast
    12.7 China Market Forecast
    12.8 Rest of World
        12.8.1 Japan
        12.8.2 Korea
        12.8.3 India

13 Research Findings and Conclusion

14 Appendix
    14.1 Research Methodology
        14.1.1 Methodology/Research Approach
            14.1.1.1 Research Programs/Design
            14.1.1.2 Market Size Estimation
            14.1.1.3 Market Breakdown and Data Triangulation
        14.1.2 Data Source
            14.1.2.1 Secondary Sources
            14.1.2.2 Primary Sources
    14.2 Author Details
    14.3 Disclaimer


List of Tables and Figures

    Figure Tofacitinib Product Picture
    Table Tofacitinib Key Market Segments
    Table Major Manufacturers Tofacitinib Covered in This Report
    Table Global Tofacitinib Market Size Growth Rate by Type 2019-2025 (K Pcs) & (Million US$)
    Figure Global Tofacitinib Sales Market Shar by Type 2014-2025
    Figure 5mg*60 Tablets Figures
    Table Major Manufacturers of 5mg*60 Tablets
    Figure 5mg*10 Tablets Figures
    Table Major Manufacturers of 5mg*10 Tablets
    Figure 10mg*10 Tablets Figures
    Table Major Manufacturers of 10mg*10 Tablets
    Figure 5mg*30 Tablets Figures
    Table Major Manufacturers of 5mg*30 Tablets
    Figure 5mg*14 Tablets Figures
    Table Major Manufacturers of 5mg*14 Tablets
    Figure 10mg*14 Tablets Figures
    Table Major Manufacturers of 10mg*14 Tablets
    Table Global Tofacitinib Market Share by Application 2019-2025 (K Pcs)
    Figure Rheumatoid Arthritis Use Case
    Figure Ulcerative Colitis Use Case
    Figure Psoriasis Use Case
    Figure Other Use Case
    Figure Tofacitinib Report Years Considered
    Figure Global Tofacitinib Market Size 2014-2025 (Million US$)
    Figure Global Tofacitinib Sales 2014-2019 (K Pcs)
    Table Global Tofacitinib Market Size by Regions 2014-2019 (K Pcs) & (Million US$)
    Table Global Tofacitinib Sales by Regions 2014-2019 (K Pcs)
    Table Global Tofacitinib Sales Market Share by Regions 2014-2019
    Figure Global Tofacitinib Sales Market Share by Regions 2014-2019
    Figure Global Tofacitinib Sales Market Share by Regions in 2019
    Table Global Tofacitinib Revenue by Regions 2014-2019 (Million US$)
    Table Global Tofacitinib Revenue Market Share by Regions 2014-2019
    Figure Global Tofacitinib Revenue Market Share by Regions 2014-2019
    Figure Global Tofacitinib Revenue Market Share by Regions in 2019
    Table Market Top Trends
    Table Global Tofacitinib Sales by Manufacturers (2014-2019) (K Pcs)
    Table Global Tofacitinib Sales Share by Manufacturers (2014-2019)
    Figure Global Tofacitinib Sales Share by Manufacturers in 2019
    Table Tofacitinib Revenue by Manufacturers (2014-2019) (Million USD)
    Table Tofacitinib Revenue Share by Manufacturers (2014-2019)
    Figure Tofacitinib Value Share by Manufacturers in 2019
    Table Global Tofacitinib Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Tofacitinib Price (2014-2019) (USD/Pcs)
    Table Key Manufacturers Tofacitinib Plants/Factories Distribution
    Table Key Manufacturers Tofacitinib Area Served
    Table Date of Key Manufacturers Enter into Tofacitinib Market
    Table Key Manufacturers Tofacitinib Product Type
    Table Mergers & Acquisitions, Expansion Plans
    Table Global 5mg*60 Tablets Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
    Table Global 5mg*10 Tablets Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
    Table Global 10mg*10 Tablets Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
    Table Global 5mg*30 Tablets Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
    Table Global 5mg*14 Tablets Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
    Table Global 10mg*14 Tablets Sales and Revenue (2014-2019) (K Pcs) & (Million US$)
    Table Global Tofacitinib Sales by Type (2014-2019) (K Pcs)
    Table Global Tofacitinib Sales Share by Type (2014-2019)
    Figure Global Tofacitinib Sales Market Share by Type (2014-2019)
    Figure Global Tofacitinib Sales Market Share by Type in 2018
    Table Global Tofacitinib Revenue by Type (2014-2019) (Million US$)
    Table Global Tofacitinib Revenue Share by Type (2014-2019)
    Figure Global Tofacitinib Revenue Market Share by Type (2014-2019)
    Figure Global Tofacitinib Revenue Market Share by Type in 2018
    Table Tofacitinib Price by Type 2014-2019 (USD/Pcs)
    Table Global Tofacitinib Sales by Application (2014-2019) (K Pcs)
    Table Global Tofacitinib Sales Share by Application (2014-2019)
    Figure Global Sales Tofacitinib Market Share by Application (2014-2019)
    Figure Global Sales Tofacitinib Market Share by Application (2014-2019)
    Figure United States Tofacitinib Sales Growth Rate 2014-2019 (K Pcs)
    Figure United States Tofacitinib Revenue Growth Rate 2014-2019 (Million US$)
    Table United States Tofacitinib Sales by Company (2014-2019) (K Pcs)
    Table United States Tofacitinib Sales Market Share by Company (2014-2019)
    Figure United States Tofacitinib Sales Market Share by Company in 2019
    Table United States Tofacitinib Sales by Type (2014-2019) (K Pcs)
    Table United States Tofacitinib Sales Market Share by Type (2014-2019)
    Figure United States Tofacitinib Market Share by Type in 2019
    Table United States Tofacitinib Sales by Application (2014-2019) (K Pcs)
    Table United States Tofacitinib Sales Market Share by Application (2014-2019)
    Figure United States Tofacitinib Market Share by Application in 2019
    Figure European Union Tofacitinib Sales Growth Rate 2014-2019 (K Pcs)
    Figure European Union Tofacitinib Revenue Growth Rate 2014-2019 (Million US$)
    Table European Union Tofacitinib Sales by Company (2014-2019) (K Pcs)
    Table European Union Tofacitinib Sales Market Share by Company (2014-2019)
    Figure European Union Tofacitinib Sales Market Share by Company in 2019
    Table European Union Tofacitinib Sales by Type (2014-2019) (K Pcs)
    Table European Union Tofacitinib Sales Market Share by Type (2014-2019)
    Figure 2018 European Union Tofacitinib Market Share by Type
    Table European Union Tofacitinib Sales by Application (2014-2019) (K Pcs)
    Table European Union Tofacitinib Sales Market Share by Application (2014-2019)
    Figure 2018 European Union Tofacitinib Market Share by Application
    Figure China Tofacitinib Sales Growth Rate 2014-2019 (K Pcs)
    Figure China Tofacitinib Revenue Growth Rate 2014-2019 (Million US$)
    Table China Tofacitinib Sales by Company (2014-2019) (K Pcs)
    Table China Tofacitinib Sales Market Share by Company (2014-2019)
    Figure China Tofacitinib Sales Market Share by Company in 2019
    Table China Tofacitinib Sales by Type (2014-2019) (K Pcs)
    Table China Tofacitinib Sales Market Share by Type (2014-2019)
    Figure China Tofacitinib Market Share by Type in 2019
    Table China Tofacitinib Sales by Application (2014-2019) (K Pcs)
    Table China Tofacitinib Sales Market Share by Application (2014-2019)
    Figure China Tofacitinib Market Share by Application in 2019
    Figure Rest of World Tofacitinib Sales Growth Rate 2014-2019 (K Pcs)
    Figure Rest of World Tofacitinib Revenue Growth Rate 2014-2019 (Million US$)
    Table Rest of World Tofacitinib Sales by Company (2014-2019) (K Pcs)
    Table Rest of World Tofacitinib Sales Market Share by Company (2014-2019)
    Figure Rest of World Tofacitinib Sales Market Share by Company in 2019
    Table Rest of World Tofacitinib Sales by Type (2014-2019) (K Pcs)
    Table Rest of World Tofacitinib Sales Market Share by Type (2014-2019)
    Figure Rest of World Tofacitinib Market Share by Type in 2019
    Table Rest of World Tofacitinib Sales by Application (2014-2019) (K Pcs)
    Table Rest of World Tofacitinib Sales Market Share by Application (2014-2019)
    Figure Rest of World Tofacitinib Market Share by Application in 2019
    Table Rest of World Tofacitinib Sales by Countries (2014-2019) (K Pcs)
    Table Rest of World Tofacitinib Sales Market Share by Countries (2014-2019)
    Figure Rest of World Tofacitinib Sales Market Share by Countries in 2019
    Table Rest of World Tofacitinib Revenue by Countries (2014-2019) (Million US$)
    Table Rest of World Tofacitinib Revenue Market Share by Countries (2014-2019)
    Figure Rest of World Tofacitinib Revenue Market Share by Countries in 2019
    Figure Japan Tofacitinib Sales Growth Rate (2014-2019) (K Pcs)
    Figure Japan Tofacitinib Revenue Growth Rate (2014-2019) (K Pcs)
    Figure Korea Tofacitinib Sales Growth Rate (2014-2019) (K Pcs)
    Figure Korea Tofacitinib Revenue Growth Rate (2014-2019) (K Pcs)
    Figure India Tofacitinib Sales Growth Rate (2014-2019) (K Pcs)
    Figure India Tofacitinib Revenue Growth Rate (2014-2019) (K Pcs)
    Figure Southeast Asia Tofacitinib Sales Growth Rate (2014-2019) (K Pcs)
    Figure Southeast Asia Tofacitinib Revenue Growth Rate (2014-2019) (K Pcs)
    Table Pfizer Company Details
    Table Pfizer Description and Business Overview
    Table Pfizer Tofacitinib Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
    Table Pfizer Tofacitinib Sales Growth Rate (2014-2019)
    Table Pfizer Tofacitinib Sales Market Share in Global Market
    Table Pfizer Recent Development
    Table Globe Pharmaceuticals Company Details
    Table Globe Pharmaceuticals Description and Business Overview
    Table Globe Pharmaceuticals Tofacitinib Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
    Table Globe Pharmaceuticals Tofacitinib Sales Growth Rate (2014-2019)
    Table Globe Pharmaceuticals Tofacitinib Sales Market Share in Global Market
    Table Globe Pharmaceuticals Recent Development
    Table Delta Pharma Limited Company Details
    Table Delta Pharma Limited Description and Business Overview
    Table Delta Pharma Limited Tofacitinib Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
    Table Delta Pharma Limited Tofacitinib Sales Growth Rate (2014-2019)
    Table Delta Pharma Limited Tofacitinib Sales Market Share in Global Market
    Table Delta Pharma Limited Recent Development
    Table Beacon Pharmaceuticals Company Details
    Table Beacon Pharmaceuticals Description and Business Overview
    Table Beacon Pharmaceuticals Tofacitinib Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
    Table Beacon Pharmaceuticals Tofacitinib Sales Growth Rate (2014-2019)
    Table Beacon Pharmaceuticals Tofacitinib Sales Market Share in Global Market
    Table Beacon Pharmaceuticals Recent Development
    Table Drug International Company Details
    Table Drug International Description and Business Overview
    Table Drug International Tofacitinib Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2014-2019)
    Table Drug International Tofacitinib Sales Growth Rate (2014-2019)
    Table Drug International Tofacitinib Sales Market Share in Global Market
    Table Drug International Recent Development
    Figure Tofacitinib Value Chain
    Table Tofacitinib Distributors List
    Table Tofacitinib Customers List
    Table Global Tofacitinib Sales Forecast 2019-2025 (K Pcs) & (Million US$)
    Figure Global Tofacitinib Sales Forecast 2019-2025 (K Pcs)
    Figure Global Tofacitinib Revenue Forecast 2019-2025 (Million US$)
    Table Global Tofacitinib Sales Forecast by Type 2019-2025 (K Pcs)
    Figure Global Tofacitinib Sales Forecast by Type 2019-2025 (K Pcs)
    Figure Global Tofacitinib Sales Market Share Forecast by Type 2019-2025
    Table Global Tofacitinib Sales Forecast by Application 2019-2025 (K Pcs)
    Figure Global Tofacitinib Sales Forecast by Application 2019-2025 (K Pcs)
    Figure Global Tofacitinib Sales Market Share Forecast by Application 2019-2025
    Table Global Tofacitinib Sales Forecast by Regions 2019-2025 (K Pcs)
    Figure Global Tofacitinib Sales Forecast by Regions 2019-2025 (K Pcs)
    Figure Global Tofacitinib Sales Market Share Forecast by Regions 2019-2025
    Table Global Tofacitinib Revenue Forecast by Regions 2019-2025 (K Pcs)
    Figure Global Tofacitinib Revenue Forecast by Regions 2019-2025 (K Pcs)
    Figure Global Tofacitinib Revenue Market Share Forecast by Regions 2019-2025
    Figure United States Tofacitinib Sales Forecast 2019-2025 (K Pcs)
    Figure United States Tofacitinib Revenue Forecast 2019-2025 (Million US$)
    Figure European Union Tofacitinib Sales Forecast 2019-2025 (K Pcs)
    Figure European Union Tofacitinib Revenue Forecast 2019-2025 (Million US$)
    Figure China Tofacitinib Sales Forecast 2019-2025 (K Pcs)
    Figure China Tofacitinib Revenue Forecast 2019-2025 (Million US$)
    Figure Japan Tofacitinib Sales Forecast 2019-2025 (K Pcs)
    Figure Japan Tofacitinib Revenue Forecast 2019-2025 (Million US$)
    Figure Korea Tofacitinib Sales Forecast 2019-2025 (K Pcs)
    Figure Korea Tofacitinib Revenue Forecast 2019-2025 (Million US$)
    Figure India Tofacitinib Sales Forecast 2019-2025 (K Pcs)
    Figure India Tofacitinib Revenue Forecast 2019-2025 (Million US$)
    Figure Southeast Asia Tofacitinib Sales Forecast 2019-2025 (K Pcs)
    Figure Southeast Asia Tofacitinib Revenue Forecast 2019-2025 (Million US$)
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources

Request sample If you need any reports sample, just let us know.